Dendritic cell vaccine
Immunotherapy using dendritic cells is an experimental form of treatment for cancer that activates the immune system to fight cancer cells. In other words dendritic cell therapy gives your immune system the instructions it needs to kill the cancer.
Dendritic cell therapy is given either after or alongside standard treatment (chemotherapy or radiotherapy) to destroy residual cancer cells and reduce the risk of recurrence. We have new studies that are currently taking place in acute myeloid leukaemia, mesothelioma and brain tumours, to look for the best ways of using immunotherapy alongside existing cancer treatments such as chemotherapy and radiotherapy. Eventually we hope to be able to use this vaccine in other types of cancer too.
So far the vaccine has been given to about 150 patients. The results have shown that these patients have a life expectancy that is increased by 60% on average, while maintaining their quality of life. A number of patients are already in partial or complete remission. The treatment has virtually no side-effects.
Do you want to support the Hero Campaign of UZA foundation?